FDAnews
www.fdanews.com/articles/11542-senate-committee-sets-april-26-for-gottliebs-fda-confirmation-vote

Senate Committee Sets April 26 for Gottlieb’s FDA Confirmation Vote

April 21, 2017

The Senate Health, Education, Labor and Pensions (HELP) Committee has scheduled April 26 for its vote on the confirmation of Scott Gottlieb to be the next commissioner of the FDA.

At his confirmation hearing earlier this month, Gottlieb said the agency should pursue alternative chronic pain treatments and look toward medical devices as therapy options (IDDM, April 10).

He was also grilled over his financial ties to the industry he would be charged with regulating, including former ties with a venture capital firm, New Enterprise Associates, that invested in a company marketing devices for treating chronic pain.

Gottlieb has pledged to recuse himself from agency decisions related to companies where he previously had a financial interest, including GlaxoSmithKline, Daiichi Sankyo and Bristol-Myers Squibb (IDDM, April 3).